La Jolla Pharmaceutical Company (LJPC) stock down -4.8% Wednesday and higher by 81.6% over the past week. LJPC stock is lower by -68.53% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives LJPC stock a score of 71 out of a possible 100.
That score is mainly influenced by a long-term technical score of 82. LJPC’s score also includes a fundamental score of 78. In addition to the average rating from Wall Street analysts, LJPC stock has a mean target price of $19.50. This means analysts expect the stock to add 101.86% over the next 12 months. The short-term technical score for LJPC is 54.
What’s Happening with LJPC Stock Today
La Jolla Pharmaceutical Company (LJPC) stock is lower by -4.83% while the S&P 500 is lower by -0.16% as of 3:22 PM on Wednesday, Jun 12. LJPC is lower by -$0.49 from the previous closing price of $10.15 on volume of 1,267,968 shares. Over the past year the S&P 500 is higher by 3.56% while LJPC is lower by -68.53%. LJPC lost -$6.84 per share in the over the last 12 months.